Navigation Links
Paul Pospisil Joins Korn/Ferry as Senior Client Partner in Biotechnology and Life Sciences Practice
Date:1/6/2011

NEW YORK, Jan. 6, 2011 /PRNewswire/ -- Korn/Ferry International (NYSE: KFY), a premier global provider of talent management solutions, today announced that Paul Pospisil, Ph.D. has joined the Firm as a Senior Client Partner in the Biotechnology and Life Sciences Practice.  He will be based out of the Firm's New York office.

Mr. Pospisil joins Korn/Ferry after serving more than 15 years as an investor and operating executive in the biotechnology industry.  He brings to the Firm strong experience in drug discovery and development, finance, business development, technology assessment and evaluation, and business strategy.

Throughout his career, Mr. Pospisil has held senior-level positions at widely-regarded consulting and venture capital firms, as well as leading globally-focused biotechnology and bio-pharmaceutical organizations.

"Paul's unique credentials as both an investor and biotechnology executive, coupled with his vast knowledge of the issues and trends driving the industry, will be a great fit for our entrepreneurial life sciences clients," said Stephen Israel, Korn/Ferry's managing director, biotechnology and pharmaceuticals.

Mr. Pospisil joins the Firm from Aduro Capital LLC, an investment management company focused on the public healthcare sector and Aduro Partners LLC, an advisory firm focused on helping venture-backed and public life science companies assess, evaluate, partner opportunities and build businesses.  Previously, he was a partner in life science investments at Atlas Venture and earlier was with Millennium Pharmaceuticals, where his last position was director, strategy leadership.  Earlier, he was a new product manager at Altus Biologics, a spin-out of Vertex Pharmaceuticals.

Mr. Pospisil received a Ph.D. in Organic Chemistry from Harvard University and a Bachelor of Arts in Biochemistry from New York
'/>"/>

SOURCE Korn/Ferry International
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Jack Davis, Diagnostics Industry Executive, Joins the HistoRx Board of Directors
2. Dr. Russell L. Chapman Joins Aquatic Energy as the Chairman of its Science Advisory Board
3. Dr. Michael Hanley Joins Celtaxsys as CEO
4. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
5. Distinguished Scientist H. Mario Geysen Joins SRI International to Lead Combinatorial Sciences and Metabolic Diseases Research Programs
6. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
7. Todd Park, Chief Technology Officer of U.S. Department of Health and Human Services, Joins Opening Keynote Line-Up at 2010 mHealth Summit
8. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
9. Excerpta Medica Joins Adelphi Worldwide
10. Philadelphia Eagles Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line
11. Christopher Bowe Joins Scrip as US Healthcare Analyst
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 Unraveling life’s mysteries can intrigue, ... Archer Family purchased a DNA test to ... up with a lifetime of memories, sharing, and closeness. ... members’ DNA genuinely brought the family closer together. ... into genetic history and prior to taking the ...
(Date:7/10/2014)... 10, 2014  Franciscan St. Anthony Health-Crown ... for respiratory monitoring outside the operating room, ... in embracing state-of-the-art patient safety technology. ... breathing and can alert medical caregivers when ... amount of carbon dioxide the patient is ...
(Date:7/10/2014)... 10, 2014   Ceres, Inc . (Nasdaq: ... announced today financial results for the three months ended ... business. Ceres reported that the company and ... this growing season in Brazil, which concluded in June, ... sorghum evaluation areas for part of the growing season. ...
(Date:7/10/2014)... of psychiatric disorders has been extremely challenging because there ... are insufficient to cause disease. Now investigators reporting in ... Cell Stem Cell describe a strategy that ... with other risk factors or environmental exposures to affect ... a genetic variant that may predispose individuals to schizophrenia. ...
Breaking Biology Technology:Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9New strategy could uncover genes at the root of psychiatric illnesses 2
... CLEVELAND, Jan. 28, 2011 Arteriocyte®, a leading ... Ohio and Hopkinton, Massachusetts that develops proprietary stem ... approval from the Food and Drug Administration (FDA) ... its Magellan MAR01™ technology in the treatment of ...
... Reportlinker.com announces that a new ... its catalogue: ... Probes and Biochips -- New Product ... for Instrument and Reagent Suppliers ...
... Calif. and HOPKINTON, Mass., Jan. 27, 2011 ... (Nasdaq: CALP ) today announced a ... for next generation sequencing sample preparation on Caliper,s ... researchers to leverage NuGEN,s Ovation® and Encore™ reagent ...
Cached Biology Technology:Arteriocyte Receives FDA Approval to Move Forward with Critical Limb Ischemia Trial 2Arteriocyte Receives FDA Approval to Move Forward with Critical Limb Ischemia Trial 3Reportlinker Adds The 2011 Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers 2NuGEN and Caliper Partner to Eliminate Next-Gen Sequencing Sample Preparation Bottlenecks 2NuGEN and Caliper Partner to Eliminate Next-Gen Sequencing Sample Preparation Bottlenecks 3
(Date:7/11/2014)... international team of researchers, including scientists from the Max ... a reported a major step in understanding photosynthesis, the ... maintains the oxygen in its atmosphere and which is ... earth. , The researchers report the first direct ... namely the step in which a specific protein complex, ...
(Date:7/11/2014)... 11, 2014 The increased risk of kidney injury ... resuscitation fluids reflects the mass of HES molecules, according ... official journal of the International Anesthesia Research Society (IARS). ... harmful effect of HES on cultured human renal proximal ... Christian Wunder and colleagues of University Hospital Wrzburg, Austria. ...
(Date:7/11/2014)... under the normal circumstances, astrocytes participate in ... environment, and exhibit therapeutic and repairing effects ... studies have found that nerve cells differentiated ... have reduced viability, which produces influences on ... Kailuan General Hospital, Hebei United University, China ...
Breaking Biology News(10 mins):A first direct glimpse of photosynthesis in action 2In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2
... Soil is the most species-rich microbial ecosystem ... certain species, give them access to the root and so ... then benefit in a variety of ways. To achieve this, ... of these bacteria are friends and which foes. Researchers from ...
... reported details of how certain drugs can precisely target ... replication. Since all strains of the virus require the ... drugs that can effectively treat new strains of the ... When new strains of influenza emerge, it can ...
... Results from a study conducted at Georgia State University ... intestines and the immune system, kicked off by another type ... disease. The study suggests that the "fight" continues after ... to Andrew Gewirtz, professor of biology at the GSU Center ...
Cached Biology News:Bacterial community inside the plant root 2Bacterial community inside the plant root 3Target for potent first-strike influenza drugs identified 2Target for potent first-strike influenza drugs identified 3Target for potent first-strike influenza drugs identified 4